Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| AMGN | NASDAQ | Amgen Inc. | $363.39 | -0.06% | 1.6M | $196.12B |
| GILD | NASDAQ | Gilead Sciences, Inc. | $129.83 | -3.72% | 5.9M | $161.19B |
| ISRG | NASDAQ | Intuitive Surgical, Inc. | $406.78 | -1.16% | 1.9M | $144.07B |
| VRTX | NASDAQ | Vertex Pharmaceuticals Incorporated | $485.39 | -2.24% | 1.4M | $123.19B |
| SNY | NASDAQ | Sanofi | $43.50 | -0.91% | 2.7M | $104.59B |
| REGN | NASDAQ | Regeneron Pharmaceuticals, Inc. | $664.52 | -0.51% | 582K | $68.46B |
| ARGX | NASDAQ | argenx SE | $877.62 | -3.50% | 325K | $54.58B |
| IDXX | NASDAQ | IDEXX Laboratories, Inc. | $563.57 | +0.89% | 613K | $44.46B |
| ALNY | NASDAQ | Alnylam Pharmaceuticals, Inc. | $298.76 | -4.49% | 2.5M | $39.89B |
| RVMD | NASDAQ | Revolution Medicines, Inc. | $186.88 | -2.22% | 1.4M | $39.73B |
| RVMDW | NASDAQ | Revolution Medicines, Inc. Warrant | $9.36 | -4.65% | 24K | $39.73B |
| NTRA | NASDAQ | Natera, Inc. | $269.95 | -4.22% | 970K | $38.66B |
| MDLN | NASDAQ | Medline Inc. | $41.04 | +0.47% | 3.1M | $34.7B |
| ONC | NASDAQ | BeOne Medicines AG | $298.70 | -1.36% | 255K | $31.92B |
| GEHC | NASDAQ | GE HealthCare Technologies Inc. | $64.70 | +0.03% | 2.6M | $29.43B |
| BIIB | NASDAQ | Biogen Inc. | $199.15 | +0.12% | 1.1M | $29.4B |
| DXCM | NASDAQ | DexCom, Inc. | $74.96 | +2.66% | 3.9M | $28.93B |
| ILMN | NASDAQ | Illumina, Inc. | $190.20 | -1.84% | 1.1M | $28.78B |
| MRNA | NASDAQ | Moderna, Inc. | $68.27 | -10.83% | 9.2M | $27.09B |
| ROIV | NASDAQ | Roivant Sciences Ltd. | $35.97 | -2.28% | 4.3M | $25.87B |
| INSM | NASDAQ | Insmed Incorporated | $115.61 | -2.24% | 2.9M | $25.06B |
| RPRX | NASDAQ | Royalty Pharma plc | $56.43 | -2.64% | 2.5M | $24.27B |
| INCY | NASDAQ | Incyte Corporation | $116.71 | -1.53% | 1.6M | $23.32B |
| UTHR | NASDAQ | United Therapeutics Corporation | $547.06 | -0.98% | 249K | $23.22B |
| BNTX | NASDAQ | BioNTech SE | $91.49 | -1.60% | 552K | $23.14B |
| GH | NASDAQ | Guardant Health, Inc. | $160.05 | -2.46% | 2M | $21.22B |
| VTRS | NASDAQ | Viatris Inc. | $16.27 | -0.43% | 7.9M | $18.95B |
| NBIX | NASDAQ | Neurocrine Biosciences, Inc. | $177.11 | -1.91% | 1M | $17.81B |
| GMAB | NASDAQ | Genmab A/S | $29.00 | -2.62% | 4.9M | $17.8B |
| BBIO | NASDAQ | BridgeBio Pharma, Inc. | $85.89 | -4.75% | 6.4M | $16.82B |
| ASND | NASDAQ | Ascendis Pharma A/S | $270.45 | -1.81% | 375K | $16.8B |
| MEDP | NASDAQ | Medpace Holdings, Inc. | $538.23 | +0.51% | 178K | $15.37B |
| JAZZ | NASDAQ | Jazz Pharmaceuticals plc | $243.82 | -1.25% | 631K | $15.32B |
| EXEL | NASDAQ | Exelixis, Inc. | $56.50 | -1.05% | 3.2M | $14.2B |
| BTSGU | NASDAQ | BrightSpring Health Services, Inc. Tangible Equity Unit | $235.22 | -0.25% | 2K | $14.09B |
| BTSG | NASDAQ | BrightSpring Health Services, Inc. Common Stock | $71.43 | -0.21% | 1.8M | $14.02B |
| COO | NASDAQ | The Cooper Companies, Inc. | $70.70 | -0.45% | 1.4M | $13.79B |
| ALGN | NASDAQ | Align Technology, Inc. | $179.45 | +0.72% | 631K | $12.85B |
| ICLR | NASDAQ | ICON Public Limited Company | $167.72 | -0.62% | 309K | $12.84B |
| MDGL | NASDAQ | Madrigal Pharmaceuticals, Inc. | $536.70 | -4.16% | 294K | $12.37B |
| AXSM | NASDAQ | Axsome Therapeutics, Inc. | $233.80 | -6.09% | 805K | $12.03B |
| SMMT | NASDAQ | Summit Therapeutics Inc. | $15.25 | -1.49% | 2.7M | $11.84B |
| BMRN | NASDAQ | BioMarin Pharmaceutical Inc. | $59.12 | -1.42% | 1.6M | $11.43B |
| PODD | NASDAQ | Insulet Corp. | $161.28 | +1.89% | 723K | $11.17B |
| TECH | NASDAQ | Bio-Techne Corporation | $71.30 | +0.21% | 2.9M | $11.16B |
| KRYS | NASDAQ | Krystal Biotech, Inc. | $365.81 | -1.46% | 364K | $10.78B |
| ARWR | NASDAQ | Arrowhead Pharmaceuticals, Inc. | $76.40 | -9.05% | 3M | $10.76B |
| CYTK | NASDAQ | Cytokinetics, Incorporated | $84.87 | -1.39% | 1.8M | $10.56B |
| ABVX | NASDAQ | Abivax S.A. | $139.90 | -0.59% | 838K | $10.27B |
| TEM | NASDAQ | Tempus AI, Inc. | $58.23 | -5.32% | 4.4M | $10.16B |